Covidien agrees to a deal that would settle a consolidated derivatives lawsuit filed by shareholders looking to block its $43 billion merger with Medtronic.
A Minnesota federal judge declines to stop Medtronic's plan to cover a $63 million tax tab stemming from its Covidien buyout for its top executives and directors.
There was a significant amount of turnover this year in the corner offices of medical device companies, including exits by some of medtech's biggest names.
There was a revolving door on medtech's corner office this year, with more than 35 CEOs leaving their positions through planned transitions, retirement or termination, according to a MassDevice.com analysis.
Medical device makers are jumping on the bandwagon of the Mr. Clean trial showing that thrombectomy is superior to medical treatment in cases of severe ischemic stroke.
Medtronic says its proposed, $43 billion acquisition of Covidien has cleared all anti-trust hurdles worldwide, setting the stage for shareholder votes next month.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Zimmer proposes divestitures for EU regulators in Biomet deal; China, South Korea OK Medtronic's $43B Covidien buy; BTG to buy PneumRx for up to $475m; BD prices $6.2B bond issue for CareFusion buy; Danaher's Leica division closes Devicor Medical buy
, Becton Dickinson & Co.
, CareFusion Corp.
, Danaher Corp.
, Devicor Medical Products
, European Commission
, Leica Biosystems
, PneumRx Inc.
Here's a look at some of the top legal news stories for medical device companies this week: Supremes decline review of Stryker loss to Hill-Rom; Appeals court vacates $177m Covidien award in spat with J&J; BMC Medical claims win in patent spat with ResMed; Ex-ArthroCare CFO wants a new trial too